# Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes

> **NCT05451342** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Acute Respiratory Failure

## Interventions

- **DIAGNOSTIC_TEST:** Integrated Transcriptomics, Metabolomics, and Lipidomics Profiling

## Key facts

- **NCT ID:** NCT05451342
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-15
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-06-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05451342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05451342, "Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05451342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*